Phagenesis
Pre-clinicalRetrain the brain. Restore swallowing control. Phagenyx® accelerates swallowing recovery from post-stroke dysphagia.
Founded
2007
Focus
NeuroscienceMedical Devices
About
Retrain the brain. Restore swallowing control. Phagenyx® accelerates swallowing recovery from post-stroke dysphagia.
Funding History
2Total raised: $28M
Series B$20MIP GroupJun 15, 2017
Series A$8MUndisclosedJun 15, 2013
Company Info
TypePrivate
Founded2007
LocationManchester, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile